Data Snapshot: Sep 05, 2026
<$50K

Aug-2026

Sales

Neutral

Trend

6-Month

4

Product Count

SKUs

$36.32

Avg Price

43.3%

YoY Sales Change

0.1%

YoY Price Change

C Minor is a highly regarded brand within the cannabis industry, offering a variety of products and related services. Their unique cultivation approach includes licensing options ranging from 'Specialty Cottage' to 'Large', to cater to various market demands, as well as a dedicated nursery for the growth of clones, immature plants, seeds, or other varieties of cannabis. Significantly conscious of user safety and legal stipulations, the company remains fully compliant with Illinois State laws and provides customers with detailed nutritional information for every edible cannabis product, along with careful pharmacological evaluations of minor cannabinoids.
C Minor Sales

Market Insights Snapshot

C Minor Historical Sales by Category

C Minor’s mix in August 2026 concentrated in Capsules at 75.67% share with year-over-year growth of 25.16% and month-over-month growth of 15.89%, while Oil held 24.33% share with year-over-year growth of 160.36% and month-over-month growth of 24.67%. Average price rose 0.11% year over year to $36.32, with Capsules priced at $34.44 and Oil at $43.72, and the brand ranked 11 in Capsules in Ontario. The pattern implies the portfolio is anchored in Capsules but is rebalancing toward faster-growing Oil, using a price ladder that keeps Capsules volume-led while Oil expands via higher absolute pricing and faster growth rates.

With total brand sales up 43.26% year over year but down 59.72% versus 24 months, the double-digit month-over-month gains in Capsules (+15.89%) and Oil (+24.67%) in August 2026 suggest recovery is being driven by mix expansion into Oil rather than pure Capsules acceleration. Holding rank 11 in Ontario Capsules alongside a 160.36% Oil year-over-year lift indicates headroom to trade consumers into higher-priced Oil without sacrificing Capsules share at 75.67%; the implication is a two-tier stance where Capsules stabilizes rank and traffic, and Oil becomes the growth lever to rebuild the longer-term decline.

Aug-2026 Rank
Capsules
Oil
11
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Capsules
75.7%
$34.44
+25.2%
+15.9%
Oil
24.3%
$43.72
+160.4%
+24.7%
C Minor

Competitive Landscape

C Minor sits at #11 in ON Capsules in August 2026, improving 3 ranks YoY from #14 and edging up 2 positions from #13 three months ago, while still 2 spots below its #9 peak from September 2024; in contrast, Glacial Gold advanced from #4 to #2 YoY and Redecan slid from #2 to #5 as its sales fell 41.1%, indicating C Minor’s modest upward movement is happening amid both upward and downward shifts among leaders. With Emprise Canada climbing from #5 to #3 on 61.4% YoY growth and Tweed dropping from #3 to #4 on a 37.1% YoY decline, C Minor’s incremental rank gains alongside a mixed top tier imply a path to re-entering the top 10 is feasible if it converts recent momentum into share capture.

C Minor market ranking for ON Capsules

C Minor

Notable Products

CBD 50 Max 3000 Oil Drops (60ml) posted the headline move in August 2026 with a +50.3% month-over-month surge while holding rank 3, outpacing CBD Isolate 100 Max 3000 Oil (30ml) at rank 2 with +14.2%. CBD Fast Acting 50 Max Softgels 30-Pack (1500mg CBD) remained rank 1 with +15.9% MoM and accounted for $27,136, indicating Capsules still anchor the leaderboard even as Oils accelerate. With three of the top four SKUs in Oils, category mix is tilting toward tinctures even though the leading Capsule retains the top rank. The pattern implies C Minor is pivoting toward higher-velocity Oils for growth while keeping Capsules as a volume stabilizer.

Product
Category
Apr-2026
May-2026
Jun-2026
Jul-2026
Aug-2026
MoM %
CBD Fast Acting 50 Max Softgels 30-Pack (1500mg CBD)
Capsules
1
1
1
1
1
+15.9%
CBD Isolate 100 Max 3000 Oil (30ml)
Oil
2
2
2
2
2
+14.2%
CBD 50 Max 3000 Oil Drops (60ml)
Oil
4
4
3
3
3
+50.3%
CBG:CBD 1:2 Max 2250 Ultra Formula Oil (30ml)
Oil
3
3
4
4
4
+32.4%
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market